Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.

Beaulieu ME, Jauset T, Massó-Vallés D, Martínez-Martín S, Rahl P, Maltais L, Zacarias-Fluck MF, Casacuberta-Serra S, Serrano Del Pozo E, Fiore C, Foradada L, Cano VC, Sánchez-Hervás M, Guenther M, Romero Sanz E, Oteo M, Tremblay C, Martín G, Letourneau D, Montagne M, Morcillo Alonso MÁ, Whitfield JR, Lavigne P, Soucek L.

Sci Transl Med. 2019 Mar 20;11(484). pii: eaar5012. doi: 10.1126/scitranslmed.aar5012.

2.

Trade agreements and drug access: assessment of the impact of the 2009 Peruvian new drug policy on anti-infectives registration and availability.

Araujo L, Montagne M.

J Pharm Policy Pract. 2018 Oct 10;11:24. doi: 10.1186/s40545-018-0151-0. eCollection 2018.

3.

Evaluation of surgical margin status in patients with early glottic cancer (Tis-T2) treated with transoral CO2 laser microsurgery, on local control.

Hendriksma M, Montagne MW, Langeveld TPM, Veselic M, van Benthem PPG, Sjögren EV.

Eur Arch Otorhinolaryngol. 2018 Sep;275(9):2333-2340. doi: 10.1007/s00405-018-5070-9. Epub 2018 Jul 19.

4.

Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.

Maltais L, Montagne M, Bédard M, Tremblay C, Soucek L, Lavigne P.

PLoS One. 2017 Mar 28;12(3):e0174413. doi: 10.1371/journal.pone.0174413. eCollection 2017.

5.

Structural Insights into c-Myc-interacting Zinc Finger Protein-1 (Miz-1) Delineate Domains Required for DNA Scanning and Sequence-specific Binding.

Bédard M, Roy V, Montagne M, Lavigne P.

J Biol Chem. 2017 Feb 24;292(8):3323-3340. doi: 10.1074/jbc.M116.748699. Epub 2016 Dec 29.

6.

Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1.

Bédard M, Maltais L, Montagne M, Lavigne P.

Proteins. 2017 Feb;85(2):199-206. doi: 10.1002/prot.25214. Epub 2016 Dec 23.

PMID:
27859590
7.

The Exploitation of Drug Users.

Stallings S, Montagne M.

Subst Use Misuse. 2015;50(8-9):948-51. doi: 10.3109/10826084.2015.1007692.

PMID:
26361899
8.

Seeing is believing, looks are deceiving: what does one see in images of drugs and drug use(rs)?

Montagne M.

Subst Use Misuse. 2015 Mar;50(4):517-9. doi: 10.3109/10826084.2015.978196. Epub 2014 Dec 26.

PMID:
25540949
9.

Methods for the expression, purification, preparation, and biophysical characterization of constructs of the c-Myc and Max b-HLH-LZs.

Beaulieu ME, McDuff FO, Bédard M, Montagne M, Lavigne P.

Methods Mol Biol. 2013;1012:7-20. doi: 10.1007/978-1-62703-429-6_2.

PMID:
24006055
10.

Pharmaceutical pictograms: a model for development and testing for comprehension and utility.

Montagne M.

Res Social Adm Pharm. 2013 Sep-Oct;9(5):609-20. doi: 10.1016/j.sapharm.2013.04.003. Epub 2013 May 14.

PMID:
23680485
11.

Drugs on the Internet, Part V: absinthe, return of the emerald mask.

Montagne M.

Subst Use Misuse. 2013 May;48(7):506-12. doi: 10.3109/10826084.2013.781451. Epub 2013 Apr 8.

PMID:
23566206
12.

Drugs on the internet, part IV: Google's Ngram viewer analytic tool applied to drug literature.

Montagne M, Morgan M.

Subst Use Misuse. 2013 Apr;48(5):415-9. doi: 10.3109/10826084.2013.763493. Epub 2013 Mar 5.

PMID:
23461625
13.

Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.

Nguyen D, Seoane-Vazquez E, Rodriguez-Monguio R, Montagne M.

BMC Health Serv Res. 2013 Jan 22;13:27. doi: 10.1186/1472-6963-13-27.

14.

Failure to consider a radically new scientific idea or theory.

Montagne M.

Subst Use Misuse. 2012 Nov-Dec;47(13-14):1469-72. doi: 10.3109/10826084.2012.705709. Review.

PMID:
23186445
15.

Drugs on the internet, part III: tobacco and smoking on the web.

Morgan M, Montagne M.

Subst Use Misuse. 2013 Jan;48(1-2):82-8. doi: 10.3109/10826084.2012.726549. Epub 2012 Oct 11.

PMID:
23050592
16.

New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.

Beaulieu ME, McDuff FO, Frappier V, Montagne M, Naud JF, Lavigne P.

J Mol Recognit. 2012 Jul;25(7):414-26. doi: 10.1002/jmr.2203.

PMID:
22733550
17.

The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.

Montagne M, Beaudoin N, Fortin D, Lavoie CL, Klinck R, Lavigne P.

PLoS One. 2012;7(2):e32172. doi: 10.1371/journal.pone.0032172. Epub 2012 Feb 22.

18.

Drugs on the Internet, part II: antidepressant medication web sites.

Morgan M, Montagne M.

Subst Use Misuse. 2011;46(13):1628-41. doi: 10.3109/10826084.2011.588878. Epub 2011 Sep 6.

PMID:
21895517
19.
20.

Drugs and the media: an introduction.

Montagne M.

Subst Use Misuse. 2011;46(7):849-51. doi: 10.3109/10826084.2011.570609.

PMID:
21599499
21.

The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.

McDuff FO, Naud JF, Montagne M, Sauvé S, Lavigne P.

J Mol Recognit. 2009 Jul-Aug;22(4):261-9. doi: 10.1002/jmr.938.

PMID:
19189276
22.

Determinants of late disease-stage presentation at diagnosis of HIV infection in Venezuela: a case-case comparison.

Bonjour MA, Montagne M, Zambrano M, Molina G, Lippuner C, Wadskier FG, Castrillo M, Incani RN, Tami A.

AIDS Res Ther. 2008 Apr 16;5:6. doi: 10.1186/1742-6405-5-6.

23.

Drugs on the internet. I: Introduction and web sites on psychedelic drugs.

Montagne M.

Subst Use Misuse. 2008;43(1):17-25. doi: 10.1080/10826080701690698.

PMID:
18189203
24.
25.

Toward the elucidation of the structural determinants responsible for the molecular recognition between Mad1 and Max.

Montagne M, Naud JF, McDuff FO, Lavigne P.

Biochemistry. 2005 Sep 27;44(38):12860-9.

PMID:
16171401
26.

Structural and thermodynamical characterization of the complete p21 gene product of Max.

Naud JF, McDuff FO, Sauvé S, Montagne M, Webb BA, Smith SP, Chabot B, Lavigne P.

Biochemistry. 2005 Sep 27;44(38):12746-58.

PMID:
16171389
27.

Darbepoetin versus epoetin.

Wu WK, Montagne M.

Am J Health Syst Pharm. 2005 Aug 1;62(15):1552, 1556; author reply 1556, 1559. No abstract available.

PMID:
16030361
28.

[Human rabies in France in 2004: update and management].

Peigue-Lafeuille H, Bourhy H, Abiteboul D, Astoul J, Cliquet F, Goudal M, Lerasle S, Mailles A, Montagne MC, Morer I, Rotivel Y, Floret D.

Med Mal Infect. 2004 Dec;34(12):551-60. Review. French.

PMID:
15603930
29.

Appreciating the user's perspective: listening to the "methadonians".

Montagne M.

Subst Use Misuse. 2002 Mar;37(4):565-70.

PMID:
12064438
30.

Mass media representations as drug information for patients: the prozac phenomenon.

Montagne M.

Subst Use Misuse. 2001 Jul-Aug;36(9-10):1261-74.

PMID:
11592472
31.

Introduction: the need for a multidimensional and multidisciplinary approach.

Lilja J, Larsson S, Montagne M.

Subst Use Misuse. 2001 Jul-Aug;36(9-10):1129-37. Review.

PMID:
11592466
32.
33.

Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).

Gobeil F Jr, Montagne M, Inamura N, Regoli D.

Immunopharmacology. 1999 Sep;43(2-3):179-85.

PMID:
10596851
34.

Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication.

Lallemand F, Courilleau D, Buquet-Fagot C, Atfi A, Montagne MN, Mester J.

Exp Cell Res. 1999 Mar 15;247(2):432-40.

PMID:
10066371
35.

Steroid Regulation of Vasoactive Intestinal Peptide (VIP).

Rostene W, Montagne MN, Dussaillant M, Gozes I I.

Stress. 1997 Oct;2(1):79-90.

PMID:
9787257
36.

[Cutaneous sarcoidosis secondary to inhalation of wall insulating material particles].

Bodokh I, Brun P, Mayaffre C, Majcwrczyk N, Montagne M.

Ann Dermatol Venereol. 1998 Mar;125(3):182-4. French.

37.

Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines.

Buquet-Fagot C, Lallemand F, Montagne MN, Mester J.

Anticancer Drugs. 1997 Jul;8(6):623-31.

PMID:
9300578
38.

[From the pharmacology of drugs to their use: formation of knowledge about psychotropic drugs].

Montagne M.

Sante Ment Que. 1997 Spring;22(1):149-63. Review. French.

PMID:
9233276
39.

Barriers to compliance with OBRA'90 regulations in community pharmacies.

Barnes JM, Riedlinger JE, McCloskey WW, Montagne M.

Ann Pharmacother. 1996 Oct;30(10):1101-5.

PMID:
8893115
40.

Estradiol induces vasoactive intestinal peptide and prolactin gene expression in the rat anterior pituitary independently of plasma prolactin levels.

Montagne MN, Dussaillant M, Chew LJ, Berod A, Lamberts SJ, Carter DA, Rostene W.

J Neuroendocrinol. 1995 Mar;7(3):225-31.

PMID:
7606249
41.

Prevention of substance use problems: models, factors, and processes.

Montagne M, Scott DM.

Int J Addict. 1993 Oct;28(12):1177-208. Review.

PMID:
8282449
42.

The argument for therapeutic use of heroin in pain management.

McCarthy RL, Montagne M.

Am J Hosp Pharm. 1993 May;50(5):992-6. No abstract available.

PMID:
8506878
43.

A chronicle of anesthesia discovery in New England.

Stallings S, Montagne M.

Pharm Hist. 1993;35(2):77-80. No abstract available.

PMID:
11623343
44.

LSD at 50: Albert Hofmann and his discovery.

Montagne M.

Pharm Hist. 1993;35(2):70-3. No abstract available.

PMID:
11623342
45.

Changes in vasoactive intestinal Peptide binding site densities in the female rat central nervous system and pituitary during lactation.

Viau V, Montagne MN, Sarrieau A, Meaney MJ, Rostène W.

J Neuroendocrinol. 1992 Dec;4(6):759-64. doi: 10.1111/j.1365-2826.1992.tb00228.x.

PMID:
21554664
46.

Drugs, music, and ideology: a social pharmacological interpretation of the Acid House Movement.

Lyttle T, Montagne M.

Int J Addict. 1992 Oct;27(10):1159-77.

PMID:
1356936
47.

Pharmacy in Lithuania and the development of a sister-school relationship between colleges of pharmacy.

Montagne M, Tarasevicius E, Kulunis R, Bleidt BA.

Am J Hosp Pharm. 1991 May;48(5):1035-8. No abstract available.

PMID:
1853866
48.

Descriptive epidemiology of international cocaine trafficking.

Montagne M.

NIDA Res Monogr. 1991;110:275-96. No abstract available.

PMID:
1944503
49.

Lesbians in currently aggressive relationships: how frequently do they report aggressive past relationships?

Lie GY, Schilit R, Bush J, Montagne M, Reyes L.

Violence Vict. 1991 Summer;6(2):121-35.

PMID:
1742239
50.

The "abuse" of oxygen.

Montagne M.

DICP. 1990 Nov;24(11):1118-9. No abstract available.

PMID:
2275245

Supplemental Content

Loading ...
Support Center